Syntax Bio expands Series A to $14.4M, inks Mayo Clinic collaboration

A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.

Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...

Syntax Bio expands Series A to $14.4M, adds leadership and board members

Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.
Los Angeles Times

English Syntax Explained

If there’s one thing you can be sure of, it’s that English Syntax can definitely get interesting. Syntax is the branch of linguistics that deals with sentences and their structures. In case you’re ...
Business Wire

Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...
The Caledonian-Record

Syntax Bio Announces Expanded Series A and Leadership Appointments

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...
Rutland Herald

Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. Collaborate to Evaluate Stem Cell Culture Technologies Using Cellgorithm™ Platform

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...